5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Dr. Agarwal's Health Care Ltd.

•
dragarwals.co.inBSE: 544350NSE: AGARWALEYE
Market Cap₹ 16,073 Cr.
Current Price
High / Low₹ 568 / 401
Stock P/E108.3
Book Value₹ 65
Price to Book6.39
Dividend Yield0.00 %
ROCE16.1 %
ROE8.7 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 34.6% CAGR over last 5 years
  • Latest quarter profit grew 44.6% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.27x)

CONS

  • Company has a low return on equity of 8.4% over last 3 years
  • Equity base is being diluted - shares outstanding up 299.7%
  • Recurring exceptional / one-off items are inflating headline profit
  • Stock is trading at 6.4x its book value
  • Though reporting repeated profits, the company pays out little dividend (0.0%)
  • Expensive relative to growth - PEG of 6.1

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY MICROCAP250NIFTY TOTAL MKT
S.No.Name
1.APOLLOHOSP8850.0060.90127249.420.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1037.2069.29100951.740.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS716.15105.5794200.740.002434.30—30906.30—13.9323.83
4.FORTIS887.3063.9366987.440.11272.802.262545.0317.4614.0721.28
5.ASTERDM762.95208.6966504.250.3929.28-68.701310.6821.6011.2619.53
6.MEDANTA1447.5569.9838920.530.03157.25-1.091304.0526.5019.3821.99
7.NH1867.3546.7638161.310.24207.275.372683.6378.0516.2017.43
8.KIMS768.85158.0632292.200.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1909.4059.1432049.051.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE507.00108.3316073.230.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1502.3082.5315473.350.1353.1037.61230.9822.8330.2842.66
12.RAINBOW1443.4051.3714660.130.2462.5416.23469.9933.1728.2528.65
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
333349403417431460487499530564614
244242300310316329360363386403545
Operating Profit8910710410711513112813614416169
OPM %26.75%30.69%25.68%25.68%26.66%28.46%26.23%27.30%27.20%28.62%11.19%
1220612131313811146
Interest2227272828252523212223
Depreciation4346565758606368697778
Profit before Tax3654273341595454657775
Tax %37.28%23.72%32.72%35.86%31.11%27.29%28.99%32.00%32.63%34.80%26.78%
Net Profit000028433836445055
0.711.390.430.570.731.040.950.941.071.251.43

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
5314716961,0181,3321,7112,0802,207
4073945147489701,2601,5091,696
Operating Profit12477182270362451571510
OPM %23.27%16.29%26.10%26.51%27.18%26.39%27.46%23.13%
1314221849545239
Interest544449761011159889
Depreciation939598128170231276292
Profit before Tax-11-485784141160249270
Tax %-81.88%-20.75%23.96%-23.49%32.38%30.97%32.38%31.49%
Net Profit-20-584310395110168185
EPS-29.93-80.871.834.0089.022.644.20—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
35%
3 Years:
27%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
12%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
19%

RETURN ON EQUITY

10 Years:
—
5 Years:
14%
3 Years:
8%
Last Year:
9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

No bonus data found

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital777893232
Minority Interest18142130406094
2421772066201,3241,8251,982
3454436159029731,2421,336
Trade Payables647589101133127149
635874109237354322
Total Liabilities7407741,0121,7702,7163,6403,915
5515757011,2931,7462,5232,870
Capital Work in Progress8112898114144234
10034471264152
33283336528094
000097124161
Cash & Bank4465117149125251129
10395132161112254274
Total Assets7407741,0121,7702,7163,6403,915

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
120107180268346357519
Cash from Investing-80-37-155-509-914-750-308
Cash from Financing-73-3735303553382-220
-50254427-15-11-10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Mar 2022Mar 2023Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
44.6237.3032.4532.4232.4232.3932.3632.34
0.000.0040.4939.1538.0237.9737.8737.91
0.000.005.216.447.927.787.837.72
Government0.000.000.000.000.000.000.000.00
31.8462.701.721.881.521.771.871.98

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-29
Copy of Newspaper Publication

2026-08-29 - Dr. Agarwal's Health Care Limited has informed the Exchange about Copy of Newspaper Publication regarding the Sixteenth Annual General Meeting of the Company, Instructions for e-Voting and Other Related Information

2026-08-28
Shareholders meeting

2026-08-28 - Notice convening the Sixteenth Annual General Meeting of Dr. Agarwal s Health Care Limited along with the Annual Report for the Financial Year 2025-2026, is submitted

2026-08-27
Press Release

2026-08-27 - Dr. Agarwal's Health Care Limited has informed the Exchange regarding a press release dated August 27, 2026, titled "Launch of World s First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwal's Eye Hospital Limited, a subsidiary of the Company.".

2026-08-25
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-25 - Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet

2026-08-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Dr. Agarwal's Health Care Limited has informed the Exchange about Transcript

2026-08-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-04 - Dr. Agarwal's Health Care Limited has informed the Exchange about Link of Recording

2026-08-04
Monitoring Agency Report

2026-08-04 - Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended June 30, 2026, is attached.

2026-08-04
Investor Presentation

2026-08-04 - Dr. Agarwal's Health Care Limited has informed the Exchange about Investor Presentation

2026-08-04
Outcome of Board Meeting

2026-08-04 - Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

News

Recent coverage and analyst commentary for AGARWALEYE

Loading news…

🤖

AI Stock Analyst

Dr. Agarwal's Health Care Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login